Great to meet @DeepakChopra and @splattfinger again today! It's always inspiring to connect with such intelligent individuals and gain insights from their wisdom.
Looking forward to discussing psychedelics, particularly ibogaine, tonight at UCF COM! It's a topic I'm truly passionate about and strongly believe in its potential to make a life-saving impact.
Diamond has received Health Canada approval to begin a Phase 2 clinical trial evaluating the safety, tolerability and efficacy of repeat low doses of psilocybin for the treatment of generalized anxiety disorder (GAD). https://t.co/9WCuT6vcyH
(Provisionally Accepted) "...evaluating the efficacy of #psilocybin combined with some form of #psychotherapy in patients with #alcohol and #tobacco use disorder. All four clinical trials indicated a beneficial effect of psilocybin-assisted therapy on SUD symptoms."
Dr. Rick Doblin’s research on treating PTSD with MDMA is adding momentum to the acceptance of psychedelics for clinical use. Learn about the hope they hold for people dealing with trauma and why he thinks it’s well past time to normalize these drugs.
https://t.co/xLKXuc3cPL
Psychedelic drugs have reemerged as tools to treat several brain disorders. As of 2022, there were hundreds of clinical trials recruiting participants for testing the therapeutic effects of psychedelics. Excited for all that comes forward in 2023.